Nucleic Acids Research · 2008 · 33 citations · 35 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTranscriptional RegulationMyc Family OncogenesOncogene ActivationTranscription Factor OncogenesTumor Suppressor Gene InactivationTumor Suppressor GenesMrna Stability ControlNeuroblastoma BiologyOncogenic DysregulationP53 InactivationPost-transcriptional Gene RegulationPost-transcriptional RegulationRna ImmunoprecipitationRna Interference-mediated Suppression
MYCN activation, mainly by gene amplification, is one of the most frequent molecular events in neuroblastoma (NB) oncogenesis, and is associated with increased malignancy and decreased neuronal differentiation propensity. The frequency of concomitant loss of heterozygosity at the 1p36.3 locus, which harbours the p53 anti-oncogene homologue TP73, indicates that MYCN and p73 alterations may cooperate in the pathogenesis of NB. We have previously shown that p73 isoforms are deregulated in NB tumours and that TAp73 co-operates synergistically with p53 for apoptosis of NB cells, whereas DeltaNp73 activates the expression of neuronal differentiation genes such as BTG2. Herein, using both ectopic expression and RNA interference-mediated silencing of p73 in MYCN amplified NB cells, we show that p73alpha isoforms inhibit MYCN expression at both transcript and protein levels, in spite of transactivator effects on MYCN promoter. To explain this paradox, we found that TAp73alpha exerts negative post-transcriptional effects leading to reduced MYCN mRNA stability. RNA immunoprecipitation experiments suggest that this dominant inhibitory post-transcriptional effect could be due to an interaction between the p73 protein and MYCN mRNA, a hypothesis also raised for the regulation of certain genes by the p53 protein.
35
An Anti-Apoptotic Role for the p53 Family Member, p73, During Developmental Neuron Death
Christine D. Pozniak, Stevo Radinovic, Annie Yang et al. · Science · 2000 · 460 citations
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Fredrik Mertens, Bertil Johansson, Mattias Höglund et al. · PubMed · 1997 · 428 citations
Life Sciences, Genetics, Oncology +17